Physician

Timothy J Wiegand, MD

According to 2025 Medicare claims, Timothy Wiegand, MD (NPI: 1467566398) practices medical toxicology in the Rochester, NY market, with the plurality of this provider's patient population coming from Monroe, NY. This provider's primary affiliated billing organization is UNIVERSITY OF ROCHESTER EMERGENCY ASSOCIATES TOXICOLOGY GROUP (NPI: 1861702334; TIN: 273682883) and primary practice location at 14642-0001.

Wiegand's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 16 traditional Medicare patients, billed 35 HCPCS/CPT codes, and received $3,159 in Medicare payments. Part D data shows 205 prescription claims across 47 beneficiaries totaling $38,411 in drug costs, led by Suboxone (Buprenorphine Hcl/Naloxone Hcl). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $28,938 to $3,159. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$14K$29K2015 Medicare payment: $28,938 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $23,618 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $18,427 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $17,102 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $16,635 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $12,025 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $8,152 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,722 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $6,850 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,159 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201583288$28,938
201683242$23,618
201768206$18,427
201883190$17,102
201966193$16,635
202048138$12,025
20214695$8,152
20223051$4,722
20233779$6,850
20241635$3,159

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$32K$65K2015 Drug cost: $25,279 (USD; Tot_Drug_Cst)2016 Drug cost: $45,259 (USD; Tot_Drug_Cst)2017 Drug cost: $47,899 (USD; Tot_Drug_Cst)2018 Drug cost: $59,830 (USD; Tot_Drug_Cst)2019 Drug cost: $57,248 (USD; Tot_Drug_Cst)2020 Drug cost: $64,621 (USD; Tot_Drug_Cst)2021 Drug cost: $55,994 (USD; Tot_Drug_Cst)2022 Drug cost: $46,226 (USD; Tot_Drug_Cst)2023 Drug cost: $62,693 (USD; Tot_Drug_Cst)2024 Drug cost: $38,411 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201543217$25,279
201652333$45,259
201768357$47,899
201878395$59,830
201968367$57,248
202062327$64,621
202148271$55,994
202251272$46,226
202360342$62,693
202447205$38,411

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Part B summary data is connected for 2024, but public code-level payment amounts are not available, so a Top 5 by total payments cannot be shown.

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
SuboxoneBuprenorphine Hcl/Naloxone Hcl27810$16,105
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl731,662$11,807
Hydroxyzine HclHydroxyzine Hcl18126$121
Ondansetron HclOndansetron Hcl1366$75
Clonidine HclClonidine Hcl17119$60

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Timothy J. Wiegand, MD?

Tedicare shows public-source Medicare data for Timothy J. Wiegand, MD (NPI 1467566398), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Timothy J. Wiegand, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Timothy J. Wiegand, MD?

Timothy J. Wiegand, MD is linked to UNIVERSITY OF ROCHESTER EMERGENCY ASSOCIATES TOXICOLOGY GROUP (billing NPI 1861702334) in the available physician profile data.

Does Timothy J. Wiegand, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.